Docetaxel treatment in castration-resistant prostate cancer: the triad gene-drug-disease

J Clin Endocrinol Metab. 2011 Feb;96(2):351-3. doi: 10.1210/jc.2010-2875.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Aromatase Inhibitors / therapeutic use
  • Docetaxel
  • Estrogens / metabolism
  • Humans
  • Male
  • Orchiectomy*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / surgery*
  • Receptors, Estrogen / drug effects
  • Receptors, Estrogen / genetics
  • Risk Factors
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents, Phytogenic
  • Aromatase Inhibitors
  • Estrogens
  • Receptors, Estrogen
  • Taxoids
  • Docetaxel